{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:22:09Z","timestamp":1760548929366},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Germline mutations in the BRCA1 gene predispose to the development of breast cancer, exhibiting a specific histological phenotype. Identification of possible hallmarks of these tumors is important for selecting patients for genetic screening and provides inside in carcinogenetic pathways.<\/jats:p><jats:p>Since BRCA1-associated breast cancers have pushing borders that prevent them from easily reaching vessels and are often of the medullary (like) type that is known to have a low rate of lympho-vascular invasion (LVI), we hypothesized that absence of LVI could characterize BRCA1 related breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A population of 68 BRCA1 related invasive breast cancers was evaluated for LVI by an experienced breast pathologist blinded to mutation status, and compared to a control group matched for age, grade and tumor type.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LVI was present in 25.0% of BRCA1 related cases, compared to 20.6% of controls (P = 0.54, OR = 1.29, CI 0.58-2.78).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LVI is frequent in BRCA1 germline mutation related breast cancers, but seems to occur as often in sporadic controls matched for age, grade and tumor type. Apparently, these hereditary cancers find their way to the blood and lymph vessels despite their well demarcation and often medullary differentiation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-10-145","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T06:13:53Z","timestamp":1271484833000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls"],"prefix":"10.1186","volume":"10","author":[{"given":"Marise R","family":"Heerma van Voss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"van der Groep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Bart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsken","family":"van der Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,16]]},"reference":[{"key":"1944_CR1","first-page":"1457","volume":"57","author":"D Ford","year":"1995","unstructured":"Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995, 57: 1457-1462.","journal-title":"Am J Hum Genet"},{"key":"1944_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/35044000","volume":"408","author":"R Scully","year":"2000","unstructured":"Scully R, Livingston DM: In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000, 408: 429-432. 10.1038\/35044000.","journal-title":"Nature"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.1038\/sj.onc.1210870","volume":"26","author":"T Thorslund","year":"2007","unstructured":"Thorslund T, West SC: BRCA2: a universal recombinase regulator. Oncogene. 2007, 26: 7720-7730. 10.1038\/sj.onc.1210870.","journal-title":"Oncogene"},{"key":"1944_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0065-2660(06)58003-4","volume":"58","author":"R Reliene","year":"2007","unstructured":"Reliene R, Bishop AJ, Schiestl RH: Involvement of homologous recombination in carcinogenesis. Adv Genet. 2007, 58: 67-87. full_text.","journal-title":"Adv Genet"},{"key":"1944_CR5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1101\/gad.14.8.927","volume":"14","author":"Y Wang","year":"2000","unstructured":"Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 2000, 14: 927-939.","journal-title":"Genes Dev"},{"key":"1944_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.dnarep.2007.02.020","volume":"6","author":"G Nagaraju","year":"2007","unstructured":"Nagaraju G, Scully R: Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst). 2007, 6: 1018-1031. 10.1016\/j.dnarep.2007.02.020.","journal-title":"DNA Repair (Amst)"},{"key":"1944_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm.2000","volume":"15","author":"E Lim","year":"2009","unstructured":"Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009, 15: 907-913. 10.1038\/nm.2000.","journal-title":"Nat Med"},{"key":"1944_CR8","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1073\/pnas.0711613105","volume":"105","author":"S Liu","year":"2008","unstructured":"Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, et al: BRCA1 regulates human mammary stem\/progenitor cell fate. Proc Natl Acad Sci USA. 2008, 105: 1680-1685. 10.1073\/pnas.0711613105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1944_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007, 25: 1329-1333. 10.1200\/JCO.2006.09.1066.","journal-title":"J Clin Oncol"},{"key":"1944_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.critrevonc.2006.01.006","volume":"59","author":"E Honrado","year":"2006","unstructured":"Honrado E, Benitez J, Palacios J: Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit Rev Oncol Hematol. 2006, 59: 27-39. 10.1016\/j.critrevonc.2006.01.006.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1944_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","volume":"31","author":"AL Bane","year":"2007","unstructured":"Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, et al: BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol. 2007, 31: 121-128. 10.1097\/01.pas.0000213351.49767.0f.","journal-title":"Am J Surg Pathol"},{"key":"1944_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van d V, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998, 90: 1138-1145. 10.1093\/jnci\/90.15.1138.","journal-title":"J Natl Cancer Inst"},{"key":"1944_CR13","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","volume":"83","author":"JE Armes","year":"1998","unstructured":"Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, et al: The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer. 1998, 83: 2335-2345. 10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N.","journal-title":"Cancer"},{"key":"1944_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/jcp.2006.042143","volume":"60","author":"SM Rodriguez-Pinilla","year":"2007","unstructured":"Rodriguez-Pinilla SM, Sarrio D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, et al: Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol. 2007, 60: 1006-1012. 10.1136\/jcp.2006.042143.","journal-title":"J Clin Pathol"},{"key":"1944_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/1078-0432.CCR-05-2098","volume":"12","author":"PJ van Diest","year":"2006","unstructured":"van Diest PJ, Groep van der P, Wall van der E: EGFR expression predicts BRCA1 status in patients with breast cancer. Clin Cancer Res. 2006, 12: 670-10.1158\/1078-0432.CCR-05-2098.","journal-title":"Clin Cancer Res"},{"key":"1944_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10549-007-9817-z","volume":"111","author":"P van der Groep","year":"2008","unstructured":"Groep van der P, Bouter A, Menko FH, van der WE, van Diest PJ: High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Cancer Res Treat. 2008, 111: 475-480. 10.1007\/s10549-007-9817-z.","journal-title":"Breast Cancer Res Treat"},{"key":"1944_CR17","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/1078-0432.CCR-04-2064","volume":"11","author":"JB Arnes","year":"2005","unstructured":"Arnes JB, Brunet JS, Stefansson I, Begin LR, Wong N, Chappuis PO, et al: Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res. 2005, 11: 4003-4011. 10.1158\/1078-0432.CCR-04-2064.","journal-title":"Clin Cancer Res"},{"key":"1944_CR18","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073\/pnas.0932692100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1944_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.pap.0000213048.69564.26","volume":"13","author":"SA Hoda","year":"2006","unstructured":"Hoda SA, Hoda RS, Merlin S, Shamonki J, Rivera M: Issues relating to lymphovascular invasion in breast carcinoma. Adv Anat Pathol. 2006, 13: 308-315. 10.1097\/01.pap.0000213048.69564.26.","journal-title":"Adv Anat Pathol"},{"key":"1944_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10434-001-0145-y","volume":"8","author":"MR Weiser","year":"2001","unstructured":"Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI, et al: Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001, 8: 145-149. 10.1007\/s10434-001-0145-y.","journal-title":"Ann Surg Oncol"},{"key":"1944_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/00000658-199911000-00012","volume":"230","author":"C Gajdos","year":"1999","unstructured":"Gajdos C, Tartter PI, Bleiweiss IJ: Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999, 230: 692-696. 10.1097\/00000658-199911000-00012.","journal-title":"Ann Surg"},{"key":"1944_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/01.sla.0000133355.48672.22","volume":"240","author":"SF Schoppmann","year":"2004","unstructured":"Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, et al: Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004, 240: 306-312. 10.1097\/01.sla.0000133355.48672.22.","journal-title":"Ann Surg"},{"key":"1944_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(02)00950-9","volume":"184","author":"CS Woo","year":"2002","unstructured":"Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, et al: Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg. 2002, 184: 337-340. 10.1016\/S0002-9610(02)00950-9.","journal-title":"Am J Surg"},{"key":"1944_CR24","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8","volume":"91","author":"ER Fisher","year":"2001","unstructured":"Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N: Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer. 2001, 91: 1679-1687. 10.1002\/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8.","journal-title":"Cancer"},{"key":"1944_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/modpathol.3800255","volume":"18","author":"TC Putti","year":"2005","unstructured":"Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, et al: Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005, 18: 26-35. 10.1038\/modpathol.3800255.","journal-title":"Mod Pathol"},{"key":"1944_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2559.2008.03201.x","volume":"54","author":"M Mannelqvist","year":"2009","unstructured":"Mannelqvist M, Stefansson I, Salvesen HB, Akslen LA: Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology. 2009, 54: 174-183. 10.1111\/j.1365-2559.2008.03201.x.","journal-title":"Histopathology"},{"key":"1944_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5","volume":"18","author":"PO Chappuis","year":"2000","unstructured":"Chappuis PO, Nethercot V, Foulkes WD: Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. Semin Surg Oncol. 2000, 18: 287-295. 10.1002\/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5.","journal-title":"Semin Surg Oncol"},{"key":"1944_CR28","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/cncr.11688","volume":"98","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, et al: Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 2003, 98: 1569-1577. 10.1002\/cncr.11688.","journal-title":"Cancer"},{"key":"1944_CR29","first-page":"1588","volume":"58","author":"F Eisinger","year":"1998","unstructured":"Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de PB, Peyrat JP, et al: Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res. 1998, 58: 1588-1592.","journal-title":"Cancer Res"},{"key":"1944_CR30","first-page":"782","volume":"6","author":"SR Lakhani","year":"2000","unstructured":"Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van d V, et al: The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res. 2000, 6: 782-789.","journal-title":"Clin Cancer Res"},{"key":"1944_CR31","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1158\/0008-5472.CAN-06-0031","volume":"66","author":"F Bertucci","year":"2006","unstructured":"Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, et al: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006, 66: 4636-4644. 10.1158\/0008-5472.CAN-06-0031.","journal-title":"Cancer Res"},{"key":"1944_CR32","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/cncr.10949","volume":"95","author":"LA Quenneville","year":"2002","unstructured":"Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, et al: HER-2\/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer. 2002, 95: 2068-2075. 10.1002\/cncr.10949.","journal-title":"Cancer"},{"key":"1944_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<263::AID-IJC11>3.0.CO;2-G","volume":"84","author":"F Eisinger","year":"1999","unstructured":"Eisinger F, Nogues C, Guinebretiere JM, Peyrat JP, Bardou VJ, Noguchi T, et al: Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer. 1999, 84: 263-267. 10.1002\/(SICI)1097-0215(19990621)84:3<263::AID-IJC11>3.0.CO;2-G.","journal-title":"Int J Cancer"},{"key":"1944_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1054\/bjoc.2001.2103","volume":"85","author":"GH de Bock","year":"2001","unstructured":"de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van d V: Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients. Br J Cancer. 2001, 85: 1347-1350. 10.1054\/bjoc.2001.2103.","journal-title":"Br J Cancer"},{"key":"1944_CR35","first-page":"1839","volume":"58","author":"M Robson","year":"1998","unstructured":"Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, et al: BRCA-associated breast cancer: absence of a characteristic immunophenotype. Cancer Res. 1998, 58: 1839-1842.","journal-title":"Cancer Res"},{"key":"1944_CR36","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, et al: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol. 2008, 26: 4282-4288. 10.1200\/JCO.2008.16.6231.","journal-title":"J Clin Oncol"},{"key":"1944_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994, 73: 643-651. 10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5.","journal-title":"Cancer"},{"key":"1944_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0046-8177(92)90313-R","volume":"23","author":"PJ van Diest","year":"1992","unstructured":"van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, et al: Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol. 1992, 23: 603-607. 10.1016\/0046-8177(92)90313-R.","journal-title":"Hum Pathol"},{"key":"1944_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bmj.325.7365.648","volume":"325","author":"PJ van Diest","year":"2002","unstructured":"van Diest PJ: No consent should be needed for using leftover body material for scientific purposes. For. BMJ. 2002, 325: 648-651. 10.1136\/bmj.325.7365.648.","journal-title":"BMJ"},{"issue":"Pt 2","key":"1944_CR40","first-page":"215","volume":"18","author":"PP Rosen","year":"1983","unstructured":"Rosen PP: Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu. 1983, 18 (Pt 2): 215-232.","journal-title":"Pathol Annu"},{"key":"1944_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bmj.325.7365.648","volume":"325","author":"PJ Van Diest","year":"2002","unstructured":"Van Diest PJ: No consent should be needed for using leftover body material for scientific purposes. For. BMJ. 2002, 325: 648-651. 10.1136\/bmj.325.7365.648.","journal-title":"BMJ"},{"key":"1944_CR42","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O","volume":"76","author":"R Lauria","year":"1995","unstructured":"Lauria R, Perrone F, Carlomagno C, De Laurentiis M, Morabito A, Gallo C, et al: The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer. 1995, 76: 1772-1778. 10.1002\/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O.","journal-title":"Cancer"},{"key":"1944_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10549-007-9875-2","volume":"112","author":"M Braun","year":"2008","unstructured":"Braun M, Flucke U, Debald M, Walgenbach-Bruenagel G, Walgenbach KJ, Holler T, et al: Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat. 2008, 112: 503-511. 10.1007\/s10549-007-9875-2.","journal-title":"Breast Cancer Res Treat"},{"key":"1944_CR44","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1200\/JCO.1990.8.9.1457","volume":"8","author":"AK Lee","year":"1990","unstructured":"Lee AK, DeLellis RA, Silverman ML, Heatley GJ, Wolfe HJ: Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol. 1990, 8: 1457-1465.","journal-title":"J Clin Oncol"},{"key":"1944_CR45","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/1097-0142(19900901)66:5<972::AID-CNCR2820660528>3.0.CO;2-O","volume":"66","author":"A Orbo","year":"1990","unstructured":"Orbo A, Stalsberg H, Kunde D: Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer. 1990, 66: 972-977. 10.1002\/1097-0142(19900901)66:5<972::AID-CNCR2820660528>3.0.CO;2-O.","journal-title":"Cancer"},{"key":"1944_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/1097-0142(19920315)69:6<1396::AID-CNCR2820690615>3.0.CO;2-I","volume":"69","author":"CG Clemente","year":"1992","unstructured":"Clemente CG, Boracchi P, Andreola S, Del VM, Veronesi P, Rilke FO: Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer. 1992, 69: 1396-1403. 10.1002\/1097-0142(19920315)69:6<1396::AID-CNCR2820690615>3.0.CO;2-I.","journal-title":"Cancer"},{"key":"1944_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0046-8177(82)80121-4","volume":"13","author":"KW Gilchrist","year":"1982","unstructured":"Gilchrist KW, Gould VE, Hirschl S, Imbriglia JE, Patchefsky AS, Penner DW, et al: Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol. 1982, 13: 170-172. 10.1016\/S0046-8177(82)80121-4.","journal-title":"Hum Pathol"},{"key":"1944_CR48","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/bcr1522","volume":"8","author":"V Birgisdottir","year":"2006","unstructured":"Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE: Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res. 2006, 8: R38-10.1186\/bcr1522.","journal-title":"Breast Cancer Res"},{"key":"1944_CR49","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/sj.onc.1202509","volume":"18","author":"A Catteau","year":"1999","unstructured":"Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999, 18: 1957-1965. 10.1038\/sj.onc.1202509.","journal-title":"Oncogene"},{"key":"1944_CR50","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000, 92: 564-569. 10.1093\/jnci\/92.7.564.","journal-title":"J Natl Cancer Inst"},{"key":"1944_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10549-004-7603-8","volume":"91","author":"E Matros","year":"2005","unstructured":"Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL: BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat. 2005, 91: 179-186. 10.1007\/s10549-004-7603-8.","journal-title":"Breast Cancer Res Treat"},{"key":"1944_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/carcin\/21.2.147","volume":"21","author":"T Bianco","year":"2000","unstructured":"Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A: Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis. 2000, 21: 147-151. 10.1093\/carcin\/21.2.147.","journal-title":"Carcinogenesis"},{"key":"1944_CR53","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr1858","volume":"10","author":"C Snell","year":"2008","unstructured":"Snell C, Krypuy M, Wong EM, Loughrey MB, Dobrovic A: BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res. 2008, 10: R12-10.1186\/bcr1858.","journal-title":"Breast Cancer Res"},{"key":"1944_CR54","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/modpathol.3800453","volume":"18","author":"E Honrado","year":"2005","unstructured":"Honrado E, Benitez J, Palacios J: The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol. 2005, 18: 1305-1320. 10.1038\/modpathol.3800453.","journal-title":"Mod Pathol"},{"key":"1944_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1075-122X.2005.00125.x","volume":"11","author":"R Prati","year":"2005","unstructured":"Prati R, Apple SK, He J, Gornbein JA, Chang HR: Histopathologic characteristics predicting HER-2\/neu amplification in breast cancer. Breast J. 2005, 11: 433-439. 10.1111\/j.1075-122X.2005.00125.x.","journal-title":"Breast J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-145\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:50:44Z","timestamp":1685566244000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,16]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-145","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,16]]},"assertion":[{"value":"28 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"145"}}